全文获取类型
收费全文 | 2084篇 |
免费 | 102篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 70篇 |
妇产科学 | 17篇 |
基础医学 | 275篇 |
口腔科学 | 27篇 |
临床医学 | 178篇 |
内科学 | 577篇 |
皮肤病学 | 37篇 |
神经病学 | 170篇 |
特种医学 | 60篇 |
外科学 | 314篇 |
综合类 | 12篇 |
预防医学 | 181篇 |
眼科学 | 22篇 |
药学 | 126篇 |
中国医学 | 3篇 |
肿瘤学 | 110篇 |
出版年
2023年 | 9篇 |
2022年 | 5篇 |
2021年 | 42篇 |
2020年 | 26篇 |
2019年 | 52篇 |
2018年 | 69篇 |
2017年 | 41篇 |
2016年 | 48篇 |
2015年 | 38篇 |
2014年 | 65篇 |
2013年 | 78篇 |
2012年 | 137篇 |
2011年 | 133篇 |
2010年 | 73篇 |
2009年 | 68篇 |
2008年 | 88篇 |
2007年 | 94篇 |
2006年 | 104篇 |
2005年 | 98篇 |
2004年 | 96篇 |
2003年 | 85篇 |
2002年 | 116篇 |
2001年 | 69篇 |
2000年 | 91篇 |
1999年 | 83篇 |
1998年 | 19篇 |
1997年 | 21篇 |
1996年 | 7篇 |
1995年 | 17篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 37篇 |
1991年 | 30篇 |
1990年 | 30篇 |
1989年 | 34篇 |
1988年 | 23篇 |
1987年 | 28篇 |
1986年 | 17篇 |
1985年 | 23篇 |
1984年 | 5篇 |
1982年 | 6篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 3篇 |
1970年 | 4篇 |
1969年 | 3篇 |
排序方式: 共有2192条查询结果,搜索用时 15 毫秒
1.
2.
3.
Andreu Nolasco Eva M. Vicent-Castelló Pamela Pereyra-Zamora Pablo Caballero-Pérez Joaquín Moncho 《Gaceta sanitaria / S.E.S.P.A.S》2019,33(6):504-510
ObjectiveTo describe the evolution of mortality risks for complications due to medical care or surgery between the periods prior to (2002-2007) and after (2008-2013) the beginning of the economic crisis for Spain and by autonomous region, and to analyse the relationship between the changes in the risks of death and the socioeconomic impact of the crisis and the variation in health spending.MethodEcological study based on age-standardized mortality rates, synthetic index of vulnerability as a socioeconomic indicator and variation in health expenditure as an indicator of health expenditure. The relative risk of death between periods was estimated with Poisson regression models.ResultsThe number of deaths increased for Spain in the period studied. Although the relationship between the increase in public investment in health and the decrease in mortality due to this cause has not been clearly demonstrated, it was possible to determine that the autonomous regions with the lowest increase in health expenditure had rates higher than the rest throughout the period, and that the most vulnerable to the crisis and with the lowest increase in spending presented the greatest increase in the risk of death between the periods.ConclusionsGiven the increase in these deaths, due to avoidable failures of the system, it is necessary to continue investigating this cause of mortality. 相似文献
4.
5.
Effects and consequences of caring for persons with heart failure: (ECCUPENIC study) a nested case–control study 下载免费PDF全文
6.
Murat Yücel Erin Oldenhof Serge H. Ahmed David Belin Joel Billieux Henrietta Bowden‐Jones Adrian Carter Samuel R. Chamberlain Luke Clark Jason Connor Mark Daglish Geert Dom Pinhas Dannon Theodora Duka Maria Jose Fernandez‐Serrano Matt Field Ingmar Franken Rita Z. Goldstein Raul Gonzalez Anna E. Goudriaan Jon E. Grant Matthew J. Gullo Robert Hester David C. Hodgins Bernard Le Foll Rico S. C. Lee Anne Lingford‐Hughes Valentina Lorenzetti Scott J. Moeller Marcus R. Munaf Brian Odlaug Marc N. Potenza Rebecca Segrave Zsuzsika Sjoerds Nadia Solowij Wim van den Brink Ruth J. van Holst Valerie Voon Reinout Wiers Leonardo F. Fontenelle Antonio Verdejo‐Garcia 《Addiction (Abingdon, England)》2019,114(6):1095-1109
7.
Andreu Porta-Sánchez Andrew C.T. Ha Xuesong Wang Fahad Almehmadi Peter C. Austin Hadas D. Fischer Atif Al-Qubbany Diego Chemello Vijay Chauhan Eugene Downar Douglas S. Lee Kumaraswamy Nanthakumar 《The Canadian journal of cardiology》2019,35(2):169-177
Background
Catheter ablation of ventricular tachycardia (VT) can reduce the burden of ventricular arrhythmia (VA) but its effect on health care utilization and costs after such therapy is poorly known. We sought to compare the rates of cardiovascular (CV)-related hospitalizations, survival, and health care costs in patients with recurrent VT treated either with VT ablation or with medical therapy.Methods
One-hundred implantable cardioverter-defibrillator patients with structural heart disease who underwent VT ablation were included. Propensity score-matched patients with recurrent VT treated with medical therapy were identified from a prospective registry of approximately 7000 de novo implantable cardioverter-defibrillator patients. Outcomes and costs were ascertained using health administrative databases.Results
Among patients who underwent VT ablation, the cumulative rates of VA-related hospitalizations were lower in the 2 years after their ablation procedure compared with the year before (rate ratio, 0.3; 95% confidence interval [CI], 0.22-0.43). Rates of CV-related hospitalization and hospitalization because of VA post index date were similar between the VT ablation and medical therapy groups (hazard ratio [HR], 0.94; 95% CI, 0.57-1.54 and HR, 1.04; 95% CI, 0.57-1.91, respectively). Health care costs in the VT ablation patients were not increased post-ablation compared with the medical management group. The risk of all-cause mortality was lower among patients in the VT ablation group relative to the medical therapy group (HR, 0.64; 95% CI, 0.4-0.99).Conclusions
Patients who underwent VT ablation experienced a significant reduction in their rate of VA-related hospitalizations. Patients treated with VT ablation had similar rates of CV-related hospitalization compared with those treated with medical therapy without increased health care-related costs. 相似文献8.
9.
10.
Vanessa Moñivas Palomero Alejandro Durante-Lopez Mario Torres Sanabria Javier Segovia Cubero Jesús González-Mirelis Jorge Vazquez Lopez-Ibor Sara M. Navarro Rico Isabel Krsnik Fernando Dominguez Alejandro Martinez Mingo Francisco J. Hernandez-Perez Gibanel Cavero Susana Mingo Santos 《Journal of the American Society of Echocardiography》2019,32(7):845-853.e1